Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 710 of 1,261
  1. US 9255155

    Antibodies specific for urokinase-type plasminogen activator and methods of treating cancer

    The Regents of the University of California · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  2. US 9255085

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  3. US 9255063

    Colchicine solid-state forms; methods of making; and methods of use thereof

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  4. US 9254327

    Methods and compositions for delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  5. US 9254280

    Medical food for cognitive decline

    The Regents of the University of California · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  6. US 2016030472

    XENON-BASED ANESTHETIC GAS COMPOSITION USABLE DURING AN ENDARTERECTOMY INVOLVING THE CLAMPING OF THE CAROTID ARTERY

    AIR LIQUIDE SANTÉ INTERNATIONAL [FR] · Granted Feb 4, 2016 · Expires Jan 30, 2036

    granted
  7. US 9249227

    Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

    VACCINEX, INC. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  8. US 9248220

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Lutonix, Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  9. US 9249217

    Bispecific EGFRvIII x CD3 antibody engaging molecules

    The United States of America, as represented by the Secretary, DHHS · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  10. US 9248119

    Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  11. US 9248172

    Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

    University of Connecticut Health Center · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  12. US 9249115

    N,N1 substituted piperazines having combined antiaggregant, anticoagulant and vasodilatory activity, and method for producing same

    Vertex Closed Joint Stock Company · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  13. US 9248136

    Transdermal hormone replacement therapies

    Compass Therapeutics LLC · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  14. US 9250239

    Compositions and methods for detecting microbial infections

    The Board of Regents of the University of Texas System · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  15. US 9249415

    Complement component C5 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  16. US 9249473

    Compositions and methods for the identification of inhibitors of retroviral infection

    TRANA DISCOVERY, INC. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  17. US 9249424

    Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases

    Regents of the University of Minnesota · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  18. US 9249243

    Antibacterial antisense oligonucleotide and method

    Sarepta Therapeutics, Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  19. US 9249225

    Single chain variable fragment anti-CD133 antibodies and uses thereof

    Regents of the University of Minnesota · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  20. US 9249179

    Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA

    Arrowhead Madison, Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  21. US 9249131

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  22. US 9249123

    Pyridinones/pyrazinones, method of making, and method of use thereof

    GILEAD CONNECTICUT, INC. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  23. US 9248195

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  24. US 9249105

    Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance Biopharma R&D IP, LLC · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.